Miralax and Tenosynovitis - a phase IV clinical study of FDA data

Summary:

Tenosynovitis is reported as a side effect among people who take Miralax (polyethylene glycol 3350), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Zometa, and have Breast cancer.

The phase IV clinical study analyzes which people have Tenosynovitis when taking Miralax. It is created by eHealthMe based on reports of 80,819 people who have side effects when taking Miralax from the FDA, and is updated regularly.

What is Miralax?

Miralax has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 81,754 Miralax users. Check the latest studies of Miralax.

What is Tenosynovitis?

Tenosynovitis (inflammation of the fluid-filled sheath (called the synovium) that surrounds a tendon) is found to be associated with 449 drugs and 491 conditions by eHealthMe. Check the latest studies of Tenosynovitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

80,819 people reported to have side effects when taking Miralax.
Among them, 17 people (0.02%) have Tenosynovitis.

Among these 17 people:

How long have people been on Miralax when they have Tenosynovitis? *

What is the gender of people who have Tenosynovitis when taking Miralax? *

female: 88.24 %
male: 11.76 %

What is the age of people who have Tenosynovitis when taking Miralax? *

What are other drugs people take besides Miralax? *

What are other side effects people have besides Tenosynovitis? *

Pain: 15 people, 88.24%
Pleural Effusion (water on the lungs): 13 people, 76.47%
Confusional State: 13 people, 76.47%
Weakness: 13 people, 76.47%
Anaemia (lack of blood): 13 people, 76.47%
Osteonecrosis Of Jaw (death of bone of jaw): 13 people, 76.47%
Weight Decreased: 12 people, 70.59%
Diarrhea: 12 people, 70.59%
Fatigue (feeling of tiredness): 12 people, 70.59%
Hair Loss: 12 people, 70.59%

What are the existing conditions these people have? *

Breast Cancer: 5 people, 29.41%
Stress And Anxiety: 2 people, 11.76%
Cardiac Failure Chronic: 2 people, 11.76%
Depression: 2 people, 11.76%
Suicide Attempt: 1 person, 5.88%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 5.88%
Breakthrough Pain: 1 person, 5.88%
Gastric Ulcer (stomach ulcer): 1 person, 5.88%
Gastritis (inflammation of stomach): 1 person, 5.88%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Miralax and have Tenosynovitis?

- Check whether Tenosynovitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Miralax:

Miralax (81,754 reports)

Tenosynovitis treatments and more:

Tenosynovitis (4,673 reports)

Browse all side effects of Miralax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tenosynovitis:

Tenosynovitis (449 drugs)

Browse all the conditions that are associated with Tenosynovitis:

Tenosynovitis (491 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on polyethylene glycol 3350 (the active ingredients of Miralax) and Miralax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.